EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Respiratory microbiome and metabolome features associate disease severity and the need for doxycycline treatment in children with macrolide-resistant Mycoplasma pneumoniae-mediated pneumonia

Wei-Chao Liao, Shiao-Wen Li, En-Wei Hsing, Sung-Han Hsiao, Ian Yi-Feng Chang, Yin-Cheng Chen, Yi-Yin Chen, Yi-Jiun Pan, Yu-Chia Hsieh

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2025.1537182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Wei-Chao Liao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Medicine Research Center, Chang Gung University, Taoyuan, Taiwan. Hauptthemen laut MEDLINE: Pneumonia, Mycoplasma, Doxycycline, Mycoplasma pneumoniae, Macrolides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Commensal bacterial community along the upper respiratory tract functions against pathogens. The host determinants of Mycoplasma pneumoniae severity should be identified against the increasing threat of macrolide-resistant M. pneumoniae (MRMP) infection. We hypothesized that respiratory microbiome is involved in the clinical manifestations of M. pneumoniae infection.

Methods

From 2017 to 2020, 92 children with MRMP-mediated pneumonia were enrolled among 845 children with community-associated pneumonia. Oropharyngeal samplings were collected within 48 h after admission. We compared respiratory microbiome and metabolites based on patients’ later development of prolonged fever and the need for doxycycline treatment (DT, n = 57) and the cured control without fever or doxycycline treatment (WDT, n = 35) by using 16S rRNA-based sequencing and untargeted metabolome analysis.

Results

Significantly higher diversity and different respiratory microbiomes were evaluated in WDT patients in contrast to DT patients. Fusobacterium , Haemophilus , Gemella , Oribacterium , Actinomyces lingnae , Fusobacterium periodonticum , Gemella sanguinis , and Solobacterium moorei were inversely correlated with disease severity. We assumed that metabolites of divergent microbiomes were related to MRMP development. We identified 15 discriminative amino-acid- and fatty-acid-related metabolites in two groups. F. periodonticum abundance was negatively associated with an inflammatory metabolite: a platelet-activating factor. Fusobacterium and Oribacterium were related to the decrease in LysoPE(18:1(9Z)/0:0) and LysoPC(18:1(9Z)).

Conclusions

Microbiota dysbiosis with dysregulated inflammatory glycerolphospholipid-related metabolites was related to disease severity and the need for doxycycline treatment in children with MRMP-mediated pneumonia. Anaerobic bacteria metabolites and metabolic pathway could be beneficial therapeutic targets against M. pneumoniae infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pneumonia, MycoplasmaDoxycyclineMycoplasma pneumoniaeMacrolidesMetabolomeAnti-Bacterial AgentsMicrobiotaDrug Resistance, BacterialHumansFemaleMaleChild, PreschoolChildSeverity of Illness IndexRNA, Ribosomal, 16SCommunity-Acquired InfectionsInfantBacteria

Stichwörter der Autor:innen

Mycoplasma pneumoniaedisease severitymacrolide-resistant Mycoplasma pneumoniaemetabolomemicrobiomepneumoniarespiratory

Substanzen

DoxycyclineMacrolidesAnti-Bacterial AgentsRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Molecular Medicine Research Center, Chang Gung University, Taoyuan, Taiwan.
  • Department of Pediatrics, Chang Gung Children's Hospital, Chang Gung Memorial Hospital, Chang Gung University, College of Medicine, Taoyuan, Taiwan.
  • Department of Life Sciences, National University of Kaohsiung, Kaohsiung, Taiwan.
  • Division of Infectious Diseases, Department of Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Institute of BioMedical Informatics, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan.

Zitieren

APA

Liao, W. C., Li, S. W., Hsing, E. W., Hsiao, S. H., Chang, I. Y., Chen, Y. C., Chen, Y. Y., Pan, Y. J., & Hsieh, Y. C. (2025). Respiratory microbiome and metabolome features associate disease severity and the need for doxycycline treatment in children with macrolide-resistant Mycoplasma pneumoniae-mediated pneumonia. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1537182

Vancouver

Liao WC, Li SW, Hsing EW, Hsiao SH, Chang IY, Chen YC, et al. Respiratory microbiome and metabolome features associate disease severity and the need for doxycycline treatment in children with macrolide-resistant Mycoplasma pneumoniae-mediated pneumonia. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1537182

BibTeX
@article{Liao2025,
  author = {Liao, Wei-Chao and Li, Shiao-Wen and Hsing, En-Wei and Hsiao, Sung-Han and Chang, Ian Yi-Feng and Chen, Yin-Cheng and Chen, Yi-Yin and Pan, Yi-Jiun and Hsieh, Yu-Chia},
  title = {Respiratory microbiome and metabolome features associate disease severity and the need for doxycycline treatment in children with macrolide-resistant Mycoplasma pneumoniae-mediated pneumonia},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1537182}
}
Kostenlos starten →